Does body mass index impact on the relationship between systolic blood pressure and cardiovascular disease?: Meta-analysis of 419 488 individuals from the Asia pacific cohort studies collaboration

Stroke

Volumn 43, Issue 6, 2012, Pages 1478-1483

  Tsukinoki, Rumi ^a,b   Murakami, Yoshitaka ^a,c   Huxley, Rachel ^d   Ohkubo, Takayoshi ^c   Fang, Xianghua ^e   Suh, Il ^f   Ueshima, Hirotsugu ^c   Lam, Tai Hing ^g   Woodward, Mark ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f Yonsei University College of Medicine   (South Korea)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

body mass index; interaction; pooled analysis; stroke subtypes; systolic blood pressure

Indexed keywords

ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ADULT; AGED; ASIA, SOUTHEASTERN; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84861588247     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.650317     Document Type: Article

References (32)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
2. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular diseases in the Asia-Pacific region. J Hypertens. 2003;21: 707-716.
3. Asia Pacific Cohort Studies Collaboration. Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004;33:751-758.
4. Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197-1209.
5. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Prospective Studies Collaboration. Body-mass index and causespecific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-223.
7. Ezzati M, Vander Hoorn S, Lopez AD, Danaei G, Rodgers A, Mathers CD, et al. Comparative quantification of mortality and burden of disease attributable to selected risk factors. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds. Global Burden of Disease and Risk Factors. Washington, DC: World Bank; 2006:241-268.
8. Barrett-Connor E, Khaw KT. Is hypertension more benign when associated with obesity? Circulation. 1985;72:53-60.
9. Carman WJ, Barrett-Connor E, Sowers M, Khaw KT. Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation. 1994;89:703-711.
10. Goldbourt U, Holtzman E, Cohen-Mandelzweig L, Neufeld HN. Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension. 1987;10:22-28.
11. Cambien F, Chretien JM, Ducimetiere P, Guize L, Richard JL. Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol. 1985;122:434-442.
12. Stamler R, Ford CE, Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-Up Program. Hypertension. 1991;17:553-564.
13. Elliott P, Shipley MJ, Jarrett RJ. Obesity and hypertension. Lancet. 1988;1:995.
14. Silventoinen K, Magnusson PK, Neovius M, Sundstrom J, Batty GD, Tynelius P, et al. Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men. Circulation. 2008;118:1637-1642.
15. Wang H, Cao J, Li J, Chen J, Wu X, Duan X, et al. Blood pressure, body mass index and risk of cardiovascular disease in Chinese men and women. BMC Public Health. 2010;10:189.
16. Bloom E, Reed D, Yano K, MacLean C. Does obesity protect hypertensives against cardiovascular diseases? JAMA. 1986;256:2972-2975.
17. Phillips A, Shaper AG. Relative weight and major ischaemic heart disease events in hypertensive men. Lancet. 1989;1:1005-1008.
18. Kannel WB, Zhang T, Garrison RJ. Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J. 1990;120: 1195-1201.
19. Bender R, Jockel KH, Richter B, Spraul M, Berger M. Body weight, blood pressure, and mortality in a cohort of obese patients. Am J Epidemiol. 2002;156:239-245.
20. Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, et al. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006;35:1412-1416.
21. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, et al; Chicago Heart Association. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: the Chicago Heart Association Detection Project in Industry Study. Hypertension. 2001;38:232-237.
22. Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension. 2003;42:69-75.
23. Parr CL, Batty GD, Lam TH, Barzi F, Fang X, Ho SC, et al; Asia-Pacific Cohort Studies Collaboration. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424 519 participants. Lancet Oncol. 2010;11:741-752.
24. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation. 2005;112:3384-3390.
25. WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Melbourne, Australia: Health Communications Australia; 2000.
26. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
27. Woodward M. Epidemiology: Study Design and Data Analysis, II ed. Boca Raton, FL: Chapman & Hall/CRC Press; 2005:450-452.
28. Dustan HP. Mechanisms of hypertension associated with obesity. Ann Intern Med. 1983;98:860-864.
29. Menotti A, Giampaoli S, Pasquali M, Seccareccia F, Stuart K. Prognosis of lean and fat hypertensives. Cardiology. 1988;75:448-457.
30. Ridker PM, Buring JE, Rifai N, Cook RN. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611-619.
31. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain MR, Massaro JM, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117:743-753.
32. Czernichow S, Ninomiya T, Huxley R, Kengne AP, Batty GD, Grobbee DE, et al. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial. Hypertension. 2010;55: 1193-1198.